Cumberland Pharmaceuticals Inc(CPIX) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
September 11 at 4:00 PM ET (Korea 9/12 05:00)
Full metrics table
| Index | - | P/E | - | EPS (ttm) | -0.73 | Insider Own | 41.6% | Shs Outstand | 15.0M | Perf Week | -0.61% |
| Market Cap | 0.10B | Forward P/E | - | EPS next Y | - | Insider Trans | - | Shs Float | 8.8M | Perf Month | -18.59% |
| Enterprise Value | 0.10B | PEG | - | EPS next Q | - | Inst Own | 16.48% | Short Float | 3.73% | Perf Quarter | 52.49% |
| Income | -0.01B | P/S | 3.1 | EPS this Y | - | Inst Trans | -6.35% | Short Ratio | 3.07 | Perf Half Y | 171.31% |
| Sales | 0.03B | P/B | 5.57 | EPS next 5Y | - | ROA | -14.91% | Short Interest | 0.33M | Perf YTD | 109.96% |
| Book/sh | 1.16 | P/C | 25.15 | EPS past 3/5Y | 20.68% 2.82% | ROE | -42.92% | 52W High | -30.17% ($9.28) | Perf Year | 146.14% |
| Cash/sh | 0.26 | P/FCF | 142.77 | Sales past 3/5Y | 1.95% 3.52% | ROIC | -50.43% | 52W Low | 351.7% ($1.43) | Perf 3Y | 419.03% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -244.92% | Gross Margin | 86.22% | Volatility(W/M) | 6.1% 7.84% | Perf 5Y | 199.51% |
| Dividend TTM | - | EV/Sales | 3.12 | Sales Y/Y TTM | -25.68% | Oper. Margin | -29.58% | ATR (14) | 0.57 | Perf 10Y | 74.46% |
| Dividend Ex-Date | 2026/8/3 | Quick Ratio | 0.96 | EPS Q/Q | -476.57% | Profit Margin | -34.92% | RSI (14) | 42.66 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 0.96 | Sales Q/Q | -98.46% | SMA20 | -13.09% ($7.46) | Beta | 0.11 | Target Price | $9.75 |
| Payout | - | Debt/Eq | 0.27 | Earnings | 2026/8/4 | SMA50 | -0.89% ($6.54) | Rel Volume | 0.39 | Prev Close | $6.29 |
| Employees | 93 | LT Debt/Eq | 0.24 | EPS/Sales Surpr. | - | SMA200 | 61.35% ($4.02) | Avg Volume(3M) | 0.11M | Price | $6.48 |
| IPO | 2009/8/11 | Option/Short | Yes/Yes | Trades | 340 | Volume | 41,274 | Change | 3.02% |
Company
CPIX is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
Cumberland Pharmaceuticals is a specialty pharmaceutical company headquartered in Nashville, Tennessee, USA. It acquires, develops, and markets branded prescription drugs in the areas of hospital acute care, gastroenterology, rheumatology, and oncology, supplying approved products through its hospital, field, and oncology sales organizations across the United States. Recently, the company has been shifting its focus toward a rare disease pipeline alongside the reshaping of its commercial portfolio.
Over the past 1 year, roughly in the middle
30% below its 1-year high.
CPIX has weak earning power
Tap to view numbers
The price looks about right
Trading at - times earnings.
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Strong Buy.
Tap to view numbers
Holding long would have paid off
Would have changed by +419.0% if bought 5 years ago.
Tap to view numbers
Dividends are hard to expect
This stock does not pay dividends
Ownership looks stable
Institutions hold 16.5%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
IWC 0.00%
DFAC 0.00%
DFAS 0.00%
DFAT 0.00%
DFSU 0.00%It ranks #4 in the industry
Based on market cap of $97M.
CPIX $97M PER -
TAK $58B PER -
TEVA $42B PER 61.1
HLN $41B PER 19.0
FAQ
What kind of company is CPIX?
CPIX belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.
What is the market cap of CPIX?
The market cap of CPIX is approximately $97M, ranking 4,569 within its sector.
What is the 52-week high and low for CPIX?
CPIX has recorded a 52-week high of $9.28 and a low of $1.43.
